Beijing Konruns Pharmaceutical Co Ltd Sustainability Reports
Beijing Konruns Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of innovative pharmaceutical products in China. Its main offerings include haemocoagulase and polypeptide formulations used for surgical bleeding control and calcium metabolism regulation.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00FPBR7B7
3 reports from 2023 to 2025
